Literature DB >> 28728983

ETV4 and AP1 Transcription Factors Form Multivalent Interactions with three Sites on the MED25 Activator-Interacting Domain.

Simon L Currie1, Jedediah J Doane1, Kathryn S Evans1, Niraja Bhachech1, Bethany J Madison1, Desmond K W Lau2, Lawrence P McIntosh2, Jack J Skalicky3, Kathleen A Clark1, Barbara J Graves4.   

Abstract

The recruitment of transcriptional cofactors by sequence-specific transcription factors challenges the basis of high affinity and selective interactions. Extending previous studies that the N-terminal activation domain (AD) of ETV5 interacts with Mediator subunit 25 (MED25), we establish that similar, aromatic-rich motifs located both in the AD and in the DNA-binding domain (DBD) of the related ETS factor ETV4 interact with MED25. These ETV4 regions bind MED25 independently, display distinct kinetics, and combine to contribute to a high-affinity interaction of full-length ETV4 with MED25. High-affinity interactions with MED25 are specific for the ETV1/4/5 subfamily as other ETS factors display weaker binding. The AD binds to a single site on MED25 and the DBD interacts with three MED25 sites, allowing for simultaneous binding of both domains in full-length ETV4. MED25 also stimulates the in vitro DNA binding activity of ETV4 by relieving autoinhibition. ETV1/4/5 factors are often overexpressed in prostate cancer and genome-wide studies in a prostate cancer cell line indicate that ETV4 and MED25 occupy enhancers that are enriched for ETS-binding sequences and are both functionally important for the transcription of genes regulated by these enhancers. AP1-motifs, which bind JUN and FOS transcription factor families, were observed in MED25-occupied regions and JUN/FOS also contact MED25; FOS strongly binds to the same MED25 site as ETV4 AD and JUN interacts with the other two MED25 sites. In summary, we describe features of the multivalent ETV4- and AP1-MED25 interactions, thereby implicating these factors in the recruitment of MED25 to transcriptional control elements.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ETS transcription factors; JUN/FOS.; Mediator complex.; Prostate cancer.

Mesh:

Substances:

Year:  2017        PMID: 28728983      PMCID: PMC5632138          DOI: 10.1016/j.jmb.2017.06.024

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  87 in total

1.  Mechanism of Mediator recruitment by tandem Gcn4 activation domains and three Gal11 activator-binding domains.

Authors:  Eric Herbig; Linda Warfield; Lisa Fish; James Fishburn; Bruce A Knutson; Beth Moorefield; Derek Pacheco; Steven Hahn
Journal:  Mol Cell Biol       Date:  2010-03-22       Impact factor: 4.272

2.  Oncogenic ETS proteins mimic activated RAS/MAPK signaling in prostate cells.

Authors:  Peter C Hollenhorst; Mary W Ferris; Megan A Hull; Heejoon Chae; Sun Kim; Barbara J Graves
Journal:  Genes Dev       Date:  2011-10-15       Impact factor: 11.361

3.  Architecture of the RNA polymerase II-Mediator core initiation complex.

Authors:  C Plaschka; L Larivière; L Wenzeck; M Seizl; M Hemann; D Tegunov; E V Petrotchenko; C H Borchers; W Baumeister; F Herzog; E Villa; P Cramer
Journal:  Nature       Date:  2015-02-04       Impact factor: 49.962

4.  A new class of yeast transcriptional activators.

Authors:  J Ma; M Ptashne
Journal:  Cell       Date:  1987-10-09       Impact factor: 41.582

5.  Structure and VP16 binding of the Mediator Med25 activator interaction domain.

Authors:  Erika Vojnic; André Mourão; Martin Seizl; Bernd Simon; Larissa Wenzeck; Laurent Larivière; Sonja Baumli; Karen Baumgart; Michael Meisterernst; Michael Sattler; Patrick Cramer
Journal:  Nat Struct Mol Biol       Date:  2011-03-06       Impact factor: 15.369

6.  Solution NMR structure of MED25(391-543) comprising the activator-interacting domain (ACID) of human mediator subunit 25.

Authors:  Alexander Eletsky; William T Ruyechan; Rong Xiao; Thomas B Acton; Gaetano T Montelione; Thomas Szyperski
Journal:  J Struct Funct Genomics       Date:  2011-07-23

7.  Transcription control by E1A and MAP kinase pathway via Sur2 mediator subunit.

Authors:  Jennitte L Stevens; Greg T Cantin; Gang Wang; Andrej Shevchenko; Anna Shevchenko; Arnold J Berk
Journal:  Science       Date:  2002-04-04       Impact factor: 47.728

8.  HMGB1-facilitated p53 DNA binding occurs via HMG-Box/p53 transactivation domain interaction, regulated by the acidic tail.

Authors:  John P Rowell; Kathryn L Simpson; Katherine Stott; Matthew Watson; Jean O Thomas
Journal:  Structure       Date:  2012-10-11       Impact factor: 5.006

9.  Structural basis for p300 Taz2-p53 TAD1 binding and modulation by phosphorylation.

Authors:  Hanqiao Feng; Lisa M Miller Jenkins; Stewart R Durell; Ryo Hayashi; Sharlyn J Mazur; Scott Cherry; Joseph E Tropea; Maria Miller; Alexander Wlodawer; Ettore Appella; Yawen Bai
Journal:  Structure       Date:  2009-02-13       Impact factor: 5.006

10.  New androgen receptor genomic targets show an interaction with the ETS1 transcription factor.

Authors:  Charles E Massie; Boris Adryan; Nuno L Barbosa-Morais; Andy G Lynch; Maxine G Tran; David E Neal; Ian G Mills
Journal:  EMBO Rep       Date:  2007-08-17       Impact factor: 8.807

View more
  17 in total

1.  Electrostatic repulsion causes anticooperative DNA binding between tumor suppressor ETS transcription factors and JUN-FOS at composite DNA sites.

Authors:  Bethany J Madison; Kathleen A Clark; Niraja Bhachech; Peter C Hollenhorst; Barbara J Graves; Simon L Currie
Journal:  J Biol Chem       Date:  2018-10-12       Impact factor: 5.157

2.  [E26 transformation-specific variant 4 promotes sorafenib and cisplatin resistance in hepatocellular carcinoma cells in vitro].

Authors:  Chen Xiaohui; L I Xin; W U Dehua
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-08-30

3.  Transcription factors perform a 2-step search of the nucleus.

Authors:  Max Valentín Staller
Journal:  Genetics       Date:  2022-09-30       Impact factor: 4.402

4.  Suppression of p53 response by targeting p53-Mediator binding with a stapled peptide.

Authors:  Benjamin L Allen; Kim Quach; Taylor Jones; Cecilia B Levandowski; Christopher C Ebmeier; Jonathan D Rubin; Timothy Read; Robin D Dowell; Alanna Schepartz; Dylan J Taatjes
Journal:  Cell Rep       Date:  2022-04-05       Impact factor: 9.995

5.  Unexpected specificity within dynamic transcriptional protein-protein complexes.

Authors:  Matthew J Henley; Brian M Linhares; Brittany S Morgan; Tomasz Cierpicki; Carol A Fierke; Anna K Mapp
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-19       Impact factor: 11.205

6.  Directed mutational scanning reveals a balance between acidic and hydrophobic residues in strong human activation domains.

Authors:  Max V Staller; Eddie Ramirez; Sanjana R Kotha; Alex S Holehouse; Rohit V Pappu; Barak A Cohen
Journal:  Cell Syst       Date:  2022-02-03       Impact factor: 11.091

7.  Gcn4-Mediator Specificity Is Mediated by a Large and Dynamic Fuzzy Protein-Protein Complex.

Authors:  Lisa M Tuttle; Derek Pacheco; Linda Warfield; Jie Luo; Jeff Ranish; Steven Hahn; Rachel E Klevit
Journal:  Cell Rep       Date:  2018-03-20       Impact factor: 9.423

8.  Conservation of coactivator engagement mechanism enables small-molecule allosteric modulators.

Authors:  Andrew R Henderson; Matthew J Henley; Nicholas J Foster; Amanda L Peiffer; Matthew S Beyersdorf; Kevon D Stanford; Steven M Sturlis; Brian M Linhares; Zachary B Hill; James A Wells; Tomasz Cierpicki; Charles L Brooks; Carol A Fierke; Anna K Mapp
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-20       Impact factor: 11.205

9.  A High-Throughput Screen for Transcription Activation Domains Reveals Their Sequence Features and Permits Prediction by Deep Learning.

Authors:  Ariel Erijman; Lukasz Kozlowski; Salma Sohrabi-Jahromi; James Fishburn; Linda Warfield; Jacob Schreiber; William S Noble; Johannes Söding; Steven Hahn
Journal:  Mol Cell       Date:  2020-05-15       Impact factor: 17.970

10.  Multivalency regulates activity in an intrinsically disordered transcription factor.

Authors:  Sarah Clark; Janette B Myers; Ashleigh King; Radovan Fiala; Jiri Novacek; Grant Pearce; Jörg Heierhorst; Steve L Reichow; Elisar J Barbar
Journal:  Elife       Date:  2018-05-01       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.